Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms
Official title: Determining the Clinical Impact and Prevalence of Hemorrhagic Subtypes in Perimesencephalic Subarachnoid Hemorrhage - A Prospective Observational Study
Run by Insel Gruppe AG, University Hospital Bern · NCT07923084 · Data updated 2026-11-12
This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 264 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | March 31, 2029 |
| Study ends | March 31, 2029 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07923084 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with non-traumatic pmSAH (or pmSAH with minimal additional blood) who have baseline CT or MRI imaging and can consent.
✕Probably not a fit
Patients with traumatic SAH, alternative aneurysm sources in the posterior circulation, or severe renal impairment may not derive direct benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects baseline imaging and patient-reported outcomes to describe the prevalence and clinical impact of hemorrhagic subtypes in perimesencephalic subarachnoid hemorrhage. Participants are adults with non-traumatic pmSAH (or pmSAH with limited adjacent blood) who provide informed consent and complete the EQ-5D questionnaire. The study analyzes PROM data alongside imaging findings to explore links between vascular lesions such as basilar artery perforator aneurysms and functional outcomes. No interventional treatment is performed; the focus is on characterization and correlation of imaging features with patient-reported quality of life. Results may improve understanding of pmSAH prognosis and guide future research on targeted management.
Why it matters
Potential benefit: If successful, findings could improve risk stratification and inform prognosis for patients with pmSAH and related lesions.
How similar studies have gone: Previous multicenter data suggest vascular lesions like BAPAs can be associated with worse outcomes, but prospective PROM-based characterization in pmSAH is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥18 years with a non-traumatic pmSAH or limited additional blood in adjacent cisterns (pmSAH "plus") * Cross-sectional imaging at baseline (CT or MRI) * Written informed consent for study participation was obtained. Exclusion Criteria: * Presence of documented written or verbal refusal * pmSAH patients with a presumed traumatic source * Saccular/fusiform aneurysm of the main arteries of the posterior circulation (e.g. V4, AICA, PICA, basilar trunk, basilar tip) * pmSAH patients with a shunting lesion in the vertebrobasilar territory (i.e. brain AVM, brain/spine AVF) * pmSAH patients with a cavernous malformation in the posterior fossa * Basilar artery perforator aneurysm group (BAPA group): * Aneurysm arising from the basilar artery trunk adjacent to a perforating branch but not involving a perforating artery (Satti Type 1) * Flow-related BAPA (i.e. AVM, AVF) * Severely impaired renal function defined as KDIGO grade 4 (GFR \<30 mL/min/1.73 m2) * Pregnancy or suspected pregnancy * Known adverse events to iodinated contrast media
Where it's running
-
Inselspital, University Hospital Bern
Bern, Switzerland Recruiting
Study contacts
- Study coordinator: Tomas Dobrocky, MD
- Email: tomas.dobrocky@insel.ch
- Phone: +41 31 632 13 77
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicenter registry for adults with spontaneous subarachnoid hemorrhage
This project collects detailed information from adults who had a spontaneous subarachnoid hemorrhage to see which treatments and care patterns lead to better outcomes.
-
Augmented kidney clearance in neurocritical care
This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.
-
Lidocaine with or without steroid infusion into the middle meningeal artery for headaches after aneurysmal subarachnoid hemorrhage
This study will try an infusion of lidocaine, with or without a steroid, into the middle meningeal artery to see if it reduces severe headaches and opioid use in adults recovering from aneurysmal subarachnoid hemorrhage.
-
Nimodipine blood levels and enantiomer differences in aneurysmal subarachnoid hemorrhage.
This project will test whether different amounts and the two forms of nimodipine get into the blood of adults with aneurysmal subarachnoid hemorrhage and whether that relates to their recovery.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Remote ischemic conditioning after aneurysm clipping for ruptured brain aneurysms
This test tries brief cycles of limb cuff inflation (remote ischemic conditioning) to see if it is safe and helps recovery in adults after surgical clipping of a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.